NCT01274481View on ClinicalTrials.gov

Iloprost Effects on Gas Exchange and Pulmonary Mechanics

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Acute Respiratory Distress SyndromeAcute Lung InjuryPulmonary Hypertension
Interventions
DRUG

Iloprost

patients inhale 20 mcg of Iloprost via nebulizer and, if oxygenation and blood pressure is maintained receive a second dose of 20 mcg of Iloprost 30 minutes later.

Trial Locations (1)

73104

OU Medical Center, Oklahoma City

Sponsors

Collaborators (1)

Actelion
All Listed Sponsors
collaborator

Actelion

INDUSTRY

lead

University of Oklahoma

OTHER